Created in 1996, the ARUP Institute for Clinical and Experimental Pathology® seeks to expand the quantity, quality, and utility of laboratory medicine. Since its inception, the Institute has developed approximately 620 tests that ARUP now performs in-house. Of these 620 tests, 335 were developed by Institute scientists, while 285 others were improved and validated so that ARUP could perform them in-house rather than continue to refer them out. Moreover, ARUP research scientists have shared their knowledge, experience, and new developments with the scientific community by publishing more than 1,000 original peer-reviewed research publications in leading journals.
The ARUP Institute’s mission is to be at the forefront of innovative research and development in clinical and experimental
laboratory medicine and to continually contribute to the profession.
The ARUP Institute's focus covers the spectrum of medical laboratory medicine:
Executive Director
|
Project CategoriesGenerally, the ARUP Institute sponsors projects within four broad categories: creating new laboratory tests; improving current clinical laboratory tests; evaluating and critiquing tests, including alpha- and beta-site protocols; and conducting basic and clinical research projects. Research performed on human subjects is conducted under informed consent following the protocols approved by the University of Utah Institutional Review Board (IRB).
|
Crockett DK, et al. Time-of-flight mass spectrometry analysis of the ferroportin-hepcidin binding domain complex for accurate mass confirmation of bioactive hepcidin 25.Clinica Chimica Acta 411(5-6):453-5. Mar 2010.
Wyness SP, et al. Performance characteristics of three random access cyclic citrullinated peptide antibody assays.Clinica Chimica Acta 411(5-6):428-32. Mar 2010.
McCudden CR, et al. Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin.Clinica Chimica Acta 411(3-4):155-60. Feb 2010.
Cloud JL, et al. Extent of interlaboratory discrepancies for polyclonal Histoplasma antigen enzyme immunoassay cannot be determined without a large split-sample study.Diagnostic Microbiology and Infectious Diseases 66(2):233-4. Feb 2010.
Merrill RM, et al. Factors and barriers influencing influenza vaccination among students at Brigham Young University.Medical Science Monitor 16(2):PH29-34. Feb 2010.
Hill HR Group A Streptococcal Carrier Versus Acute Infection: The Continuing Dilemma..Clinical Infectious Diseases 50(4):491-2. Feb 2010.